Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study. / Olloni, Agon; Brink, Carsten; Lorenzen, Ebbe Laugaard; Jeppesen, Stefan Starup; Hofmann, Lone; Kristiansen, Charlotte; Knap, Marianne Marquard; Møller, Ditte Sloth; Nygård, Lotte; Persson, Gitte Fredberg; Thing, Rune Slot; Sand, Hella Maria Brøgger; Diederichsen, Axel; Schytte, Tine.

In: JTO Clinical and Research Reports, Vol. 5, No. 4, 100663, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Olloni, A, Brink, C, Lorenzen, EL, Jeppesen, SS, Hofmann, L, Kristiansen, C, Knap, MM, Møller, DS, Nygård, L, Persson, GF, Thing, RS, Sand, HMB, Diederichsen, A & Schytte, T 2024, 'Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study', JTO Clinical and Research Reports, vol. 5, no. 4, 100663. https://doi.org/10.1016/j.jtocrr.2024.100663

APA

Olloni, A., Brink, C., Lorenzen, E. L., Jeppesen, S. S., Hofmann, L., Kristiansen, C., Knap, M. M., Møller, D. S., Nygård, L., Persson, G. F., Thing, R. S., Sand, H. M. B., Diederichsen, A., & Schytte, T. (2024). Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study. JTO Clinical and Research Reports, 5(4), [100663]. https://doi.org/10.1016/j.jtocrr.2024.100663

Vancouver

Olloni A, Brink C, Lorenzen EL, Jeppesen SS, Hofmann L, Kristiansen C et al. Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study. JTO Clinical and Research Reports. 2024;5(4). 100663. https://doi.org/10.1016/j.jtocrr.2024.100663

Author

Olloni, Agon ; Brink, Carsten ; Lorenzen, Ebbe Laugaard ; Jeppesen, Stefan Starup ; Hofmann, Lone ; Kristiansen, Charlotte ; Knap, Marianne Marquard ; Møller, Ditte Sloth ; Nygård, Lotte ; Persson, Gitte Fredberg ; Thing, Rune Slot ; Sand, Hella Maria Brøgger ; Diederichsen, Axel ; Schytte, Tine. / Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study. In: JTO Clinical and Research Reports. 2024 ; Vol. 5, No. 4.

Bibtex

@article{7378a41abcf24e65ab5ec6c433fdcc9c,
title = "Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study",
abstract = "Introduction: It is an ongoing debate how much lung and heart irradiation impact overall survival (OS) after definitive radiotherapy for lung cancer. This study uses a large national cohort of patients with locally advanced NSCLC to investigate the association between OS and irradiation of lung and heart. Methods: Treatment plans were acquired from six Danish radiotherapy centers, and patient characteristics were obtained from national registries. A hybrid segmentation tool automatically delineated the heart and substructures. Dose-volume histograms for all structures were extracted and analyzed using principal component analyses (PCAs). Parameter selection for a multivariable Cox model for OS prediction was performed using cross-validation based on bootstrapping. Results: The population consisted of 644 patients with a median survival of 26 months (95% confidence interval [CI]: 24–29). The cross-validation selected two PCA variables to be included in the multivariable model. PCA1 represented irradiation of the heart and affected OS negatively (hazard ratio, 1.14; 95% CI: 1.04–1.26). PCA2 characterized the left-right balance (right atrium and left ventricle) irradiation, showing better survival for tumors near the right side (hazard ratio, 0.92; 95% CI: 0.84–1.00). Besides the two PCA variables, the multivariable model included age, sex, body-mass index, performance status, tumor dose, and tumor volume. Conclusions: Besides the classic noncardiac risk factors, lung and heart doses had a negative impact on survival, while it is suggested that the left side of the heart is a more radiation dose–sensitive region. The data indicate that overall heart irradiation should be reduced to improve the OS if possible.",
keywords = "Definitive radiotherapy, Dose to heart chambers and coronary arteries, Heart dose, Lung dose, NSCLC, Overall survival",
author = "Agon Olloni and Carsten Brink and Lorenzen, {Ebbe Laugaard} and Jeppesen, {Stefan Starup} and Lone Hofmann and Charlotte Kristiansen and Knap, {Marianne Marquard} and M{\o}ller, {Ditte Sloth} and Lotte Nyg{\aa}rd and Persson, {Gitte Fredberg} and Thing, {Rune Slot} and Sand, {Hella Maria Br{\o}gger} and Axel Diederichsen and Tine Schytte",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors",
year = "2024",
doi = "10.1016/j.jtocrr.2024.100663",
language = "English",
volume = "5",
journal = "JTO Clinical and Research Reports",
issn = "2666-3643",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study

AU - Olloni, Agon

AU - Brink, Carsten

AU - Lorenzen, Ebbe Laugaard

AU - Jeppesen, Stefan Starup

AU - Hofmann, Lone

AU - Kristiansen, Charlotte

AU - Knap, Marianne Marquard

AU - Møller, Ditte Sloth

AU - Nygård, Lotte

AU - Persson, Gitte Fredberg

AU - Thing, Rune Slot

AU - Sand, Hella Maria Brøgger

AU - Diederichsen, Axel

AU - Schytte, Tine

N1 - Publisher Copyright: © 2024 The Authors

PY - 2024

Y1 - 2024

N2 - Introduction: It is an ongoing debate how much lung and heart irradiation impact overall survival (OS) after definitive radiotherapy for lung cancer. This study uses a large national cohort of patients with locally advanced NSCLC to investigate the association between OS and irradiation of lung and heart. Methods: Treatment plans were acquired from six Danish radiotherapy centers, and patient characteristics were obtained from national registries. A hybrid segmentation tool automatically delineated the heart and substructures. Dose-volume histograms for all structures were extracted and analyzed using principal component analyses (PCAs). Parameter selection for a multivariable Cox model for OS prediction was performed using cross-validation based on bootstrapping. Results: The population consisted of 644 patients with a median survival of 26 months (95% confidence interval [CI]: 24–29). The cross-validation selected two PCA variables to be included in the multivariable model. PCA1 represented irradiation of the heart and affected OS negatively (hazard ratio, 1.14; 95% CI: 1.04–1.26). PCA2 characterized the left-right balance (right atrium and left ventricle) irradiation, showing better survival for tumors near the right side (hazard ratio, 0.92; 95% CI: 0.84–1.00). Besides the two PCA variables, the multivariable model included age, sex, body-mass index, performance status, tumor dose, and tumor volume. Conclusions: Besides the classic noncardiac risk factors, lung and heart doses had a negative impact on survival, while it is suggested that the left side of the heart is a more radiation dose–sensitive region. The data indicate that overall heart irradiation should be reduced to improve the OS if possible.

AB - Introduction: It is an ongoing debate how much lung and heart irradiation impact overall survival (OS) after definitive radiotherapy for lung cancer. This study uses a large national cohort of patients with locally advanced NSCLC to investigate the association between OS and irradiation of lung and heart. Methods: Treatment plans were acquired from six Danish radiotherapy centers, and patient characteristics were obtained from national registries. A hybrid segmentation tool automatically delineated the heart and substructures. Dose-volume histograms for all structures were extracted and analyzed using principal component analyses (PCAs). Parameter selection for a multivariable Cox model for OS prediction was performed using cross-validation based on bootstrapping. Results: The population consisted of 644 patients with a median survival of 26 months (95% confidence interval [CI]: 24–29). The cross-validation selected two PCA variables to be included in the multivariable model. PCA1 represented irradiation of the heart and affected OS negatively (hazard ratio, 1.14; 95% CI: 1.04–1.26). PCA2 characterized the left-right balance (right atrium and left ventricle) irradiation, showing better survival for tumors near the right side (hazard ratio, 0.92; 95% CI: 0.84–1.00). Besides the two PCA variables, the multivariable model included age, sex, body-mass index, performance status, tumor dose, and tumor volume. Conclusions: Besides the classic noncardiac risk factors, lung and heart doses had a negative impact on survival, while it is suggested that the left side of the heart is a more radiation dose–sensitive region. The data indicate that overall heart irradiation should be reduced to improve the OS if possible.

KW - Definitive radiotherapy

KW - Dose to heart chambers and coronary arteries

KW - Heart dose

KW - Lung dose

KW - NSCLC

KW - Overall survival

U2 - 10.1016/j.jtocrr.2024.100663

DO - 10.1016/j.jtocrr.2024.100663

M3 - Journal article

C2 - 38590728

AN - SCOPUS:85189132950

VL - 5

JO - JTO Clinical and Research Reports

JF - JTO Clinical and Research Reports

SN - 2666-3643

IS - 4

M1 - 100663

ER -

ID: 387979791